All Audiences

Kura Oncology’s Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society’s Pediatric Acute Leukemia (PedAL) Master Clinical Trial

Latest FDA Approval in Multiple Myeloma May Reduce Treatment Costs, Frequency and Side Effects

The Leukemia & Lymphoma Society 2025 Research Grants Include Acute Leukemia in Children with Down Syndrome

The Leukemia & Lymphoma Society Announces Reimagined Executive Leadership Team

The Leukemia & Lymphoma Society Denounces Federal Actions that Threaten Cancer Patients

The Leukemia & Lymphoma Society (LLS) Data and Presence at ASH Showcase Latest Blood Cancer Treatment Breakthroughs

The Leukemia & Lymphoma Society (LLS) Data at ASH Provides Glimpse into the Future of Blood Cancer Treatment

The Leukemia & Lymphoma Society Receives $17 Million from the Mike and Sofia Segal Family Foundation to Accelerate Progress in the Treatment of Chronic Myelomonocytic Leukemia

The Leukemia & Lymphoma Society's Response to the Israel-Hamas War

The Leukemia & Lymphoma Society Teams Up with Kappa Alpha Psi Fraternity To Educate And Empower Communities About Blood Cancer

Subscribe to All Audiences

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.